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Supplementary figure legends 
Fig. S1: Senescent endothelial cells exhibit enhanced Arg-II expression and activity. (A)
SA-ȕ-gal staining in young (Y) and senescent (S) HUVECs. (B) Immunoblotting analysis of 
senescence markers p53-S15, p53, and p21Cip1 levels, and endothelial inflammation markers 
VCAM1 and ICAM1 expression. Tubulin served as protein loading control. (C)
Immunoblotting analysis of Arg-II protein levels and arginase activity. ***p<0.005 vs Y
group. Scale bar = 0.2 mm.
Fig. S2: Overexpression of Arg-II gene in young cells induces eNOS uncoupling, 
endothelial senescence, and inflammation. Young endothelial cells were transduced with 
empty rAd/CMV vector as control (con) or rAd/CMV-Arg-II to overexpress Arg-II. (A)
Immunoblotting analysis of Arg-II overexpression. (B) DHE staining for detection of O2.- and 
DAF-2DA staining for detection of NO, and effect of the eNOS inhibitor L-NAME (1 
mmol/L, 1 hour). Bar graphs show quantifications of DHE and DAF-2DA signals. (C) SA-ȕ-
gal staining. Bar graphs show quantifications of percentage of SA-ȕ-gal positive cells. (D)
Immunoblotting analysis of senescence markers p53-S15, p53, and p21Cip1 levels, and 
endothelial inflammation markers VCAM1 and ICAM1 expression. Tubulin serves as loading 
control. Bar graphs show quantifications of the markers. **p<0.01, ***p<0.005 vs
control; †p<0.05 vs Arg-II. Scale bar = 0.2 mm.
Fig. S3: Enzymatic activity dependence of the Arg-II-promoted endothelial aging in 
young cells. The young endothelial cells were transduced with empty rAd/CMV vector as 
control (con), rAd/CMV-Arg-II to overexpress wild type Arg-II or with rAd/CMV-Arg-II
(H160F) to overexpress the inactive Arg-II mutant. (A) Immunoblotting analysis of Arg-II
overexpression. (B) DHE staining for detection of O2.- and DAF-2DA staining for detection 
of NO. Bar graphs show quantifications of DHE and DAF-2DA signals. (C) SA-ȕ-gal 
staining. Bar graphs show quantifications of percentage of SA-ȕ-gal positive cells. (D) 
Immunoblotting analysis of p53-S15, p53, p21Cip1 levels, VCAM1, and ICAM1 expression. 
2Tubulin serves as loading control. Bar graphs show quantifications of the markers. *p<0.05, 
**p<0.01, ***p<0.005 vs control; ††<0.01, †††p<0.005 vs Arg-II. Scale bar = 0.2 mm.
Fig. S4: Silencing Arg-II prevents S6K1-induced Arg-II expression and arginase 
activity. Young HUVECs were first transduced either with rAd/U6-LacZshRNA as control or 
rAd/U6-Arg-IIshRNA. Four days post transduction with rAd/U6-shRNA, cells were then 
transduced either with rAd/CMV as control (con) or rAd/CMV-HA-S6K1ca (a constitutively 
active S6K1 mutant). Experiments were performed on day two post 2nd transduction. Cells 
were serum starved with 0.2% FCS-RPMI 12 hours prior to experiments. Blots above reveal 
the immunoblotting analysis of HA-tagged S6K1ca and Arg-II with anti-HA and anti-Arg-II 
antibody, respectively. Bar graphs below show quantifications of Arg-II/tubulin protein level, 
arginase activity, and Arg-II/GAPDH mRNA levels as analysed by qRT-PCR. ***p<0.005 vs 
control; †††p<0.005 vs S6K1ca.
Figure S5: Deficiency in Arg-II gene in mice (Arg-II-/-) improves eNOS function in aging.
(A) Immunofluorescence confocal microscopy showing en face detection of aortic endothelial 
O2.- (DHE staining) and NO production (DAF-2DA staining) in young (2–3 months) and old 
(23–24 months) WT and Arg-II-/- mice followed by counterstaining with DAPI for endothelial 
nuclei. (B) Bar graphs show quantifications of DHE and DAF-2DA signals. **p<0.01, 
***p<0.005 vs young WT mice; †p<0.05, †††p<0.005 vs old WT mice. Scale bar = 100 ȝP
Fig. S6: S6K1 activity in aging is positively regulated by Arg-II. Immunoblotting analysis 
of S6-S235/S236 (p-S6) and total S6 in (A) aortas of young (2–3 months) and old (23–24 
months) WT and Arg-II-/- mice and (B) senescent endothelial cells transduced with LacZshRNA
as control or Arg-IIshRNA. Bar graphs below show quantifications of the above experiments. 
**p<0.01, ***p<0.005 vs young WT mice or LacZshRNA group; †††p<0.005 vs old WT mice.
(C) Scheme illustrating mutual positive crosstalk between S6K1 and Arg-II in endothelial 
aging. 






